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Flexible organic light-emitting diodes for antimicrobial
photodynamic therapy
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Ifor D. W. Samuel 1
Bacterial infection and the growth of antibiotic resistance is a serious problem that leads to patient suffering, death and increased
costs of healthcare. To address this problem, we propose using ﬂexible organic light-emitting diodes (OLEDs) as light sources for
photodynamic therapy (PDT) to kill bacteria. PDT involves the use of light and a photosensitizer to generate reactive oxygen species
that kill neighbouring cells. We have developed ﬂexible top-emitting OLEDs with the ability to tune the emission peak from 669 to
737 nm to match the photosensitizer, together with high irradiance, low driving voltage, long operational lifetime and adequate
shelf-life. These features enable OLEDs to be the ideal candidate for ambulatory PDT light sources. A detailed study of OLED–PDT
for killing Staphylococcus aureus was performed. The results show that our OLEDs in combination with the photosensitizer
methylene blue, can kill more than 99% of bacteria. This indicates a huge potential for using OLEDs to treat bacterial infections.
npj Flexible Electronics            (2019) 3:18 ; https://doi.org/10.1038/s41528-019-0058-0
INTRODUCTION
Bacterial infection has been a serious issue for centuries. The
discovery of antibiotics has signiﬁcantly improved the life
expectancy of human beings by providing effective antimicrobial
treatment.1 However, the widespread use of antibiotics has
increased the drug resistance of bacteria and resulted in loss of
impact in killing bacteria efﬁciently.2 It is estimated that antibiotic-
resistant bacteria will cause 10 million deaths per year by 2050.3
The problem of drug-resistant bacteria not only poses a threat to
health but also means a growing economic burden in developing
expensive newer-generation antibiotics and managing infection.4
An estimation of global economic loss due to antimicrobial
resistance has been made to be $100 trillion in total by 2050, if we
do not take action.5 To address this problem, it is necessary to
explore some other approaches to treating bacterial infection.
Photodynamic therapy (PDT) is a commonly used therapeutic
method in dermatology for skin cancer and acne treatment. By
activating the photosensitizer with light sources at suitable
wavelengths, cytotoxic reactive oxygen species (mainly singlet
oxygen) can be created and then kill cells, where a photosensitizer
and light are applied. Antimicrobial PDT (aPDT) has been known
for more than 20 years, and researchers have demonstrated its
effectiveness on a range of strains of bacteria.6–9 Some studies
have shown the effectiveness of aPDT on drug-resistant
bacteria,10,11 and very encouragingly, no drug-resistant behaviour
was observed even after 20 consecutive in vitro treatments and
regrowth.12 PDT is normally administered using large hospital-
based light sources, and so in spite of the evidence showing that it
can offer an alternative approach to treating bacterial infections,
the specialized light sources used have so far been an important
factor limiting its adoption.
Lasers, inorganic light-emitting diodes (LEDs) and broad-
spectrum discharge lamps are the three main types of light
sources that have been used in clinical PDT treatments.13 Lasers
have a high-power output and narrow spectrum to achieve
efﬁcient absorption of photosensitizers, but they are restricted by
being expensive, needing eye protection for patients and
operators and having a limited selection of wavelengths. Inorganic
LED-based light sources are highly efﬁcient, and arrays of LEDs can
achieve large-area treatment; however, as currently implemented
in the clinic, they are cumbersome and expensive. Although
ambulatory PDT has been demonstrated by using inorganic LEDs,
the emission uniformity is limited by the point-source nature of
individual LEDs in the array.14 Broad-spectrum discharge lamps
have advantages in adapting to photosensitizers with different
absorption peaks by using colour ﬁlters, but the heating problem
remains unsolved, which can cause an undesirable outcome.15
Hence, the wider use of PDT requires new light sources that make
it easily accessible, so that it can be moved out of a specialized
hospital and be done anytime, anywhere. Ambulatory light
sources are desirable and should be able to deliver high irradiance
(>5mW/cm2) and uniform emission (<5% variation), with ade-
quate operational lifetime (<3% decay in 3 h) and suitable
wavelengths. Therefore, a new generation of light sources for
PDT needs to be developed to realize these requirements.
Compared with the light sources described above, organic light-
emitting diodes (OLEDs) are attractive for PDT, because they are
intrinsically area light sources (hence uniform) that are also
lightweight and thin, with the potential to be scaled up to a large
area.16,17 Moreover, OLEDs can be deposited onto ﬂexible
substrates that are conformable to human skin, which makes
them promising for wearable medical devices.18–24 The successful
demonstration of OLED–PDT for treating skin cancer has raised
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interest in using compact and uniform light sources for PDT.25
Recently, quantum-dot LED-based medical devices have also been
demonstrated in PDT.26,27 In addition to the form factor
advantages, the peak wavelength of top-emitting OLEDs can be
tuned by simply varying the transport layer thickness of devices.28
By tuning the emission spectrum, the overlap between OLED
emission and photosensitizer absorption can be optimized; hence,
more reactive oxygen species can be generated. In terms of low-
cost healthcare, OLEDs can be made in solution processes, such as
spin-coating, blade-coating and ink-jet printing. These processes
radically reduce the cost of manufacturing and will relieve the
economic burden of developing expensive drugs.29,30 Thus, it is
worth exploring the potential of OLEDs in medical applications,
especially in aPDT.
In this paper, we demonstrate effective aPDT to kill Staphylo-
coccus aureus (S. aureus) by using ﬂexible OLEDs as PDT light
sources and methylene blue (MB) as the photosensitizer. Flexible
top-emitting OLEDs based on the p–i–n (p-doped, intrinsic, n-
doped) structure were used to enhance the conductivity of OLEDs.
By adopting the p–i–n structure, the power consumption of
devices can be signiﬁcantly lowered.31 Moreover, it enables us to
make top-emitting OLEDs, where the emission spectrum can be
tuned without changing the device conductivity. This makes
OLEDs a good light source candidate for PDT, because it widens
the potential range of photosensitizers by providing more
matching wavelengths. In our work, 4-cm2 large-area ﬂexible
OLEDs were shown to have a high optical output density (>9mW/
cm2) at 25 mA/cm2, high emission uniformity, long operational
lifetime and a reasonable shelf-life. Furthermore, we evaluated the
effectiveness of OLEDs with MB on killing S. aureus. Here, a low-
dose rate and longer treatment time were used to simulate the
ambulatory PDT condition in clinical treatment.25 The results
showed that OLEDs as PDT light sources kill bacteria effectively,
especially with longer treatment time and higher MB concentra-
tions. Our results suggest an attractive way of treating bacterial
infections and pave the way for more wearable healthcare devices
based on organic electronics in the future.
RESULTS
Design of the OLED structure
To perform effective PDT, the wavelength of the light source
should be carefully chosen. Compared with other wavelengths,
red light of wavelength 600–700 nm is ideal for PDT, because it
enables light penetration into tissues, whilst avoiding the
absorption peaks of water and oxygenated haemoglobin.32,33
MB is a classic photosensitizer with a broad absorption spectrum
ranging from 500 to 700 nm and an absorption peak at
662 nm.34,35 In order to generate a substantial amount of reactive
oxygen species, the emission of the OLEDs needs to be strongly
absorbed by the photosensitizer to deliver effective photoexcita-
tion. The emission wavelength of OLEDs is highly dependent on
the emitting material used in emission layer. Bis(2-methyldibenzo
[f,h]quinoxaline)(acetylacetonate) iridium(III) [Ir(MDQ)2(acac)] is a
well-studied efﬁcient red emitter, which has a photoluminescence
(PL) peak at 610 nm in N,N′-Bis(naphthalen-1-yl)-N,N′-bis(phenyl)-
benzidine (NPB) host.36–38 As shown in Fig. 1a, there is good
overlap of the emission spectrum of Ir(MDQ)2(acac) and the
absorption spectrum of MB, so effective photoexcitation of the
photosensitizer is expected.
Wearable electronics require low driving voltage to be driven by
batteries. However, conventional OLEDs usually have a high
driving voltage, which means more batteries are needed to drive
the devices. For ambulatory PDT, a higher driving voltage often
leads to local heating, which can cause an adverse effect during
the treatment.34 There are three main solutions for heating
management in terms of device structure. First, improve the
external quantum efﬁciency of devices, which means less power
consumption for same amount of light output. Second, design the
metal contact with a special pattern to reduce the sheet resistance
of a thin electrode, so less voltage drop across the devices. Third,
Fig. 1 Design of 16-mm2 ﬂexible OLEDs. a Photoluminescence spectrum of Ir(MDQ)2(acac) and absorption spectrum of methylene blue. b
Device structure of ﬂexible p–i–n OLED. c Electroluminescence spectra of OLEDs with 40, 50, 60 and 70-nm HTL thicknesses. d J–V
characteristics of OLEDs with 40, 50, 60 and 70-nm HTL thicknesses
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increase the conductivity of devices by adding extra dopant or
applying material with higher conductivity to reduce the Joule
heating. To reduce the driving voltage, we used doped transport
layer structure, known as p–i–n structure to achieve high
conductivity (Fig. 1b). The hole transport layer (HTL) with
2,2′,7,7′-tetra(N,N-di-p-tolyl)amino-9,9-spirobiﬂuorene (Spiro-TTB)
was doped by 2,2-(perﬂuoronaphthalene-2,6-diylidene)dimalono-
nitrile (F6-TCNNQ) and electron transport layer 4,7-diphenyl-1,10-
phenanthroline (BPhen) was doped by Cs. A hole-blocking layer
bis(8-hydroxy-2-methylquinoline)-(4-phenylphenoxy)aluminium
(BAlq) and electron-blocking layer NPB are used to conﬁne the
excitons within the emission layer. Top-emitting OLEDs, with Al
bottom electrode and a semitransparent silver top electrode, were
deposited onto the 16-mm2 polyethylene terephthalate (PET)
barrier ﬁlm substrates (LINTEC Corporation). The 40-nm NPB on
the PET ﬁlm is to passivate the substrate, and NPB capping layer
on the top electrode is to enhance the light outcoupling. After the
deposition, PET barrier layer was laminated on the device for
encapsulation.
Because of the reﬂective bottom contact and the semi-
transparent top contact, the top-emitting OLEDs exhibit a very
strong microcavity effect.39 Microcavity effects have been used in
OLEDs to optimize the light extraction. Here, we show that it is
also promising for PDT applications because the emission peak
can be tuned to match the absorption of photosensitizer. We
varied the thickness of the HTL (x= 40–70 nm), and the emission
peak of OLEDs shifts from 669 to 737 nm (Fig. 1c). Therefore, a
very convenient spectrum tuning can be achieved by simply
varying the transport layer thickness in top-emitting OLEDs.
Increasing the transport layer thickness often results in a higher
driving voltage, but this is not the case of p–i–n OLEDs. The
devices with different thicknesses of doped transport layers have
very similar current density–voltage (J–V) characteristics (Fig. 1d),
which means the spectrum can be tuned in a wide range of
wavelength without changing the device conductivity. This
broadens the selection of photosensitizers, since the spectral
overlap can be enhanced by shifting the OLEDs emission from the
original peak.
Large-area ﬂexible OLEDs for PDT
In order to apply OLEDs to PDT, we scaled up the ﬂexible OLEDs to
4-cm2 with 70-nm HTL thickness (Fig. 2a). The ﬂexible OLEDs
delivers an irradiance of 9.85 mW/cm2 at 25mA/cm2 with a driving
voltage of 3.82 V only (Fig. 2b). For ambulatory PDT, an irradiance
of around 5mW/cm2 is usually applied, which means our 4-cm2
ﬂexible OLEDs have sufﬁcient light output for this application. The
spectral overlap of ﬂexible OLEDs and MB is shown in Fig. 2c, a
signiﬁcant fraction of the OLED spectrum overlaps with the MB
absorption. This indicates an effective energy transfer from light
sources to photosensitizers; in other words, reactive oxygen
species can be created effectively through this process. As OLEDs
are very sensitive to moisture and oxygen, effective encapsulation
is needed. Commercially available PET barrier ﬁlms were used as
the substrates and encapsulation ﬁlms to protect the OLEDs. The
ﬂexible OLEDs were encapsulated by laminating PET barrier ﬁlm
with UV-curable epoxy glue onto the fabricated OLEDs. A
lamination process is suitable for ﬂexible OLEDs for PDT because
it is low-cost and high throughput. By using this encapsulation
method, we achieved a resonable shelf-life for the ﬂexible OLEDs
with only a few dark spots at the edge after 10 days, and most
parts of devices still emit light after 91 days (Fig. S1). Heat
generation can shorten device lifetime, so we attached the OLEDs
to a ﬂexible graphite heat sink. The ﬂexible OLEDs were then
driven at a constant current density to deliver an initial irradiance
of 7.75 mW/cm2. They showed very stable emission over 13 h with
<1% intensity decay, which far exceeds the requirements of our
experiments in which at most 6 h of illumination is required
(Fig. 2d).
Biological results of OLED–PDT on S. aureus
The efﬁcacy of OLEDs on glass and PET substrates for killing S.
aureus (PCM 502, ATCC 12600) were tested on 96-well plates
Fig. 2 Design and performance of 4-cm2 ﬂexible OLEDs. a Photos of 4-cm2 ﬂexible OLED. b V–J-irradiance characteristics of 4-cm2 ﬂexible
OLED. c Emission spectrum of 4-cm2 ﬂexible OLED and absorption spectrum of methylene blue. d 4-cm2 ﬂexible OLED driven at a constant
current density of 25 mA/cm2 for the operational lifetime test
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(Falcon® 96 Well Clear Microplate). The details of OLEDs on glass
substrates are shown in Fig. S2 and Table S1. In this study, the
growth of live bacteria was monitored using a CLARIOstar®
Microplate Reader (BMG LABTECH) to measure the optical density
(OD) of bacteria at 450-nm wavelength (OD450), which does not
activate the photosensitizer. To investigate the killing effect of
OLEDs under different bacterial concentrations, the original
bacterial suspension was diluted in nutrient broth to OD600 equal
to 0.001 or 0.005. In addition, the ﬁnal MB concentrations of 1.25
and 5 µg/mL were used. Details of allocation of control groups and
groups irradiated by light are shown in Fig. S3. The OLEDs on glass
substrates have an emission peak at 610 nm, which is shorter than
the OLEDs on PET substrates. To compensate for the difference in
spectral overlap with the photosensitizer, the irradiance of the
OLEDs on glass substrates was set to 5 mW/cm2, whereas 6 mW/
cm2 was used for OLEDs on PET subtrates. The reason for applying
low irradiance in the experiment is to simulate the low irradiance
and long treatment time for OLED–PDT in the clinic to reduce the
risk of discomfort being caused by the treatment.25
The results of OLED–PDT on S. aureus are shown in Fig. 3. For
the experiment with OLEDs on glass substrates, the irradiation
times were 1, 3 and 6 h, which corresponds to the doses of 18, 54
and 108 J/cm2. For the experiment with OLEDs on PET substrates,
the bacteria were irradiated for 3 h (64.8 J/cm2) and 6 h (129.6 J/
cm2). As shown in Fig. 3a, b, the presence of OLEDs has a
signiﬁcant effect on S. aureus especially at longer treatment times.
MB at 5 µg/mL showed high toxicity on S. aureus, but the killing
rate was greatly enhanced with the combination of OLEDs. The
high killing rate of bacteria under the irradiation of OLEDs
indicates that OLED–PDT has a pronounced impact on antimicro-
bial treatment.
The ﬂexible OLEDs on PET substrates had also been tested as
shown in Fig. 3c, d. At OD 0.001, OLEDs with 5 µg/mL MB had an
obvious effect on bacteria at 3 h. The groups of 6-h OLED
irradiation showed a high killing rate at both 1.25 and 5 µg/mL MB
concentrations. Even for the OD 0.005, the group with 1.25 µg/mL
MB and OLED irradiation has <40% of bacteria at 3 and 6 h.
Groups with 5 µg/mL MB and OLED irradiation have <10% of
bacteria at 3 and 6 h.
DISCUSSION
In summary, ﬂexible OLEDs for aPDT provide an attractive method
for killing bacteria. Flexible OLEDs have several advantages such
as being conformable to human skin, lightweight, thin and with
high emission uniformity, thereby opening a pathway to
ambulatory treatment of superﬁcial bacterial infections such as
wounds. The ﬂexible red OLEDs were designed to be top-emitting
and used a p–i–n structure to enable low driving voltage and
spectral tuning. By simply varying the thickness of the HTL, the
emission peak shifted within 669–737 nm without changing the
conductivity. We then demonstrated 4-cm2 OLEDs with high
irradiance, low driving voltage, good spectral overlap with a
photosensitizer, long operational lifetime and reasonable shelf-life
for killing bacteria. The experiment of OLED–PDT for killing S.
aureus was performed with OLEDs on glass substrates and OLEDs
on ﬂexible substrates. For both types of device, the combination
of the OLEDs with MB showed more than 99% killing of bacteria at
OD 0.001 for 3 h of illumination.
The successful demonstration of OLEDs for killing bacteria
provides a promising direction for antimicrobial treatment. It
shows that OLEDs are very attractive as a new generation of light
source for medical applications. It paves the way for further light
therapy and diagnosis based on organic optoelectronics.
METHODS
Thin-ﬁlm preparation: The 50 nm 10 wt% Ir(MDQ)2(acac) (2-methyldibenzo
[f,h]quinoxaline) (acetylacetonate)iridium(III)-doped NPB (N,N′-bis
Fig. 3 Biological results of OLED–PDT for killing S. aureus. The results show the fraction of bacteria alive for a range of conditions of
illumination and photosensitizer concentrations. Each set of ﬁve bars shows the results for a control (no light, no photosensitizer); 1.25 µg/mL
methylene blue but no light; 1.25 µg/mL methylene blue with OLED illumination for the stated times; 5 µg/mL methylene blue but no light;
5 µg/mL methylene blue with OLED illumination for the stated times. For each set of conditions performed with OLEDs on glass substrates,
there were three biological repetitions, each with three technical repetitions, i.e. nine samples were measured (n= 9). For the experiments
performed with OLEDs on ﬂexible substrates, three samples were measured in each condition (n= 3). The mean and standard deviation of
each set of measurements is shown. Statistical signiﬁcance compared to control (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)
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(naphthalen-1-yl)-N,N′-bis(phenyl)-benzidine) was deposited on quartz
substrate using the thermal evaporator (EvoVac, Angstrom Engineering
Inc.) at a base pressure of 3 × 10−7 mbar.
Photophysical property measurement: The absorption spectrum of MB
was measured using a UV−vis spectrophotometer (Cary 300, Varian), and
PL spectrum of Ir(MDQ)2(acac) in NPB was measured using a spectrometer
(FLS980, Edinburgh Instruments).
OLED fabrication: OLEDs were fabricated with thermal evaporation
either on bare glass substrates or on PET barrier ﬁlms (LINTEC Corporation).
HTL and emission layer were deposited at 0.6 Å/s; hole blocking layer and
electron blocking layer were at 0.3 Å/s; electron transport layer and Ag
cathode were at 1 Å/s; Al anode was at 3 Å/s; NPB capping layer was at 2 Å/
s. The ﬂexible OLEDs were encapsulated with epoxy glue and PET barrier
ﬁlm by lamination.
OLED characterization: The electrical characteristics of OLEDs were
measured with a source metre. (Keithley 2400, Keithley). EL spectra of the
OLEDs were obtained using a spectrograph (MS125, Oriel) coupled to a
charge coupled device (CCD) camera (DV420-BU, Andor). The irradiance
and operational lifetime of OLEDs were measured with an optometer
(P9710, Gigahertz Optik). Emission uniformity measurement of OLEDs was
done by a power metre (PM100USB, Thorlabs).
Photosensitizer solution preparation: The solution of MB in the PBS
(137mM NaCl; 2.7 mM KCl; 1 mM Na2HPO4; 1.8 mM KH2PO4, pH 7.4) was
prepared in the dark and in sterile conditions. In addition, the solution was
puriﬁed on the syringe ﬁlter with a 0.22-µm pore size (Millex-HP syringe-
driven ﬁlter unit, Millipore). The original concentration of a photosensitizer
solution was 250 µg/mL of PBS, stored in the dark at 4 °C.
Bacterial strain and culture condition: The S. aureus culture was grown
overnight in lysogeny broth (LB) medium at 37 °C in shaking incubator. The
bacterial suspension was standardized by OD measuring at the wavelength
600 nm (OD600), which was measured with Cell density metre (The
Biochrom WPA CO 8000). Over 24 h, the bacterial culture was diluted in LB
to gain OD600 equal to 0.01.
Biological experimental setup: Two concentrations of bacteria were
used. The original bacterial suspension (OD600 of 0.01) was diluted in
nutrient broth (Nutrient Broth No. 2, CM0067, Thermo Scientiﬁc) to OD600
of 0.001 or 0.005. The diluted bacterial suspension was subdivided into the
groups of samples shown in Tables S2 and S3, and MB was added if
needed. Each group of samples had a negative control without bacteria
cells (Background). Experiments were performed on 96-well plates (Falcon®
96 Well Clear Microplate). For each set of conditions studied with OLEDs on
glass substrate, there were three biological repetitions, each with three
technical repetitions (n= 9). For each set of conditions studied with OLEDs
on ﬂexible substrate, three samples were measured (n= 3). The samples
were irradiated for the times shown in Tables S2 and S3. During the
irradiation the plate was located in optimal condition for bacteria growth
(37 °C, 1 atm, pH~7.5). After photoactivation samples on 96-well plates
were centrifuged at 4700 rpm, 5 min, Room temperature. Two hundred
microlitres of supernatant ﬂuid was replaced by 200 µL of fresh nutrient
broth medium. Measurement protocol: The measurement was carried out
in CLARIOstar® Microplate Reader (BMG LABTECH) for at least 20 h. The
bacteria grow in the optimal conditions in the dark. The measurement was
based on the OD at 450 nm. This wavelength does not activate the
photosensitizer, is safe for bacteria and has been used previously for OD
measurements. The technical speciﬁcation of measurement is presented in
Table S4.
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